<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Microbiol.</abbrev-journal-title>
</journal-title-group>
<issn pub-type="epub">1664-302X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmicb.2026.1770614</article-id>
<article-version article-version-type="Version of Record" vocab="NISO-RP-8-2008"/>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Original Research</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Transcutaneous electrical nerve stimulation treated anterior talo-fibular ligament injured rat through the gut-joint axis and intestinal microbiota</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Nan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ma</surname>
<given-names>Tong</given-names>
</name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="https://credit.niso.org/contributor-roles/data-curation/">Data curation</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chen</surname>
<given-names>Ran</given-names>
</name>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/3113647"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhang</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role>reviewer</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Xun</given-names>
</name>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="methodology" vocab-term-identifier="https://credit.niso.org/contributor-roles/methodology/">Methodology</role>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Sun</surname>
<given-names>Yan</given-names>
</name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/752615"/>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="conceptualization" vocab-term-identifier="https://credit.niso.org/contributor-roles/conceptualization/">Conceptualization</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="https://credit.niso.org/contributor-roles/project-administration/">Project administration</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; review &#x0026; editing" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-review-editing/">Writing &#x2013; review &#x0026; editing</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="https://credit.niso.org/contributor-roles/writing-original-draft/">Writing &#x2013; original draft</role>
<role vocab="credit" vocab-identifier="https://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="https://credit.niso.org/contributor-roles/funding-acquisition/">Funding acquisition</role>
</contrib>
</contrib-group>
<aff id="aff1"><label>1</label><institution>Trauma Center, First Affiliated Hospital of Kunming Medical University, Kunming Medical University</institution>, <city>Kunming</city>, <state>Yunnan</state>, <country country="cn">China</country></aff>
<aff id="aff2"><label>2</label><institution>Key Laboratory of Pharmacology for Natural Products of Yunnan Province, Pharmaceutical College, Kunming Medical University</institution>, <city>Kunming</city>, <state>Yunnan</state>, <country country="cn">China</country></aff>
<aff id="aff3"><label>3</label><institution>Clinical Lab, Second Affiliated Hospital of Kunming Medical University</institution>, <city>Kunming</city>, <state>Yunnan</state>, <country country="cn">China</country></aff>
<aff id="aff4"><label>4</label><institution>CAS Key Laboratory of Animal Models and Human Disease Mechanisms, KIZ-SU Joint Laboratory of Animal Model and Drug Development, Laboratory of Learning and Memory, Kunming Institute of Zoology, The Chinese Academy of Sciences</institution>, <city>Kunming</city>, <country country="cn">China</country></aff>
<author-notes>
<corresp id="c001"><label>&#x002A;</label>Correspondence: Yan Sun, <email xlink:href="mailto:553046530@qq.com">553046530@qq.com</email></corresp>
<fn fn-type="other" id="fn0001"><label>&#x2020;</label><p>ORCID: Nan Chen, <uri xlink:href="https://orcid.org/0009-0007-7782-0129">orcid.org/0009-0007-7782-0129</uri>; Tong Ma, <uri xlink:href="https://orcid.org/0009-0003-6688-0418">orcid.org/0009-0003-6688-0418</uri>; Ran Chen, <uri xlink:href="https://orcid.org/0000-0002-4434-9453">orcid.org/0000-0002-4434-9453</uri>; Yang Zhang, <uri xlink:href="https://orcid.org/0009-0002-6562-1345">orcid.org/0009-0002-6562-1345</uri>; Xun Tang, <uri xlink:href="https://orcid.org/0000-0002-0716-6180">orcid.org/0000-0002-0716-6180</uri>; Yan Sun, <uri xlink:href="https://orcid.org/0000-0002-3388-1807">orcid.org/0000-0002-3388-1807</uri></p>
</fn>
</author-notes>
<pub-date publication-format="electronic" date-type="pub" iso-8601-date="2026-02-23">
<day>23</day>
<month>02</month>
<year>2026</year>
</pub-date>
<pub-date publication-format="electronic" date-type="collection">
<year>2026</year>
</pub-date>
<volume>17</volume>
<elocation-id>1770614</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="rev-recd">
<day>31</day>
<month>01</month>
<year>2026</year>
</date>
<date date-type="accepted">
<day>06</day>
<month>02</month>
<year>2026</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2026 Chen, Ma, Chen, Zhang, Tang and Sun.</copyright-statement>
<copyright-year>2026</copyright-year>
<copyright-holder>Chen, Ma, Chen, Zhang, Tang and Sun</copyright-holder>
<license>
<ali:license_ref start_date="2026-02-23">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License (CC BY)</ext-link>. The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<sec>
<title>Objective</title>
<p>This study demonstrated that transcutaneous electrical nerve stimulation (TENS) and its induced fecal microbiota transplantation (FMT) could treat anterior talo-fibular ligament (ATFL) injury rat and modify the intestinal microbiota via the gut-joint axis.</p>
</sec>
<sec>
<title>Methods</title>
<p>An ATFL injury model was duplicated and treated with low, medium, or high-intensity of TENS. After 1, 2, and 3&#x202F;weeks of TENS treatment, the improvements and the expression levels of NOD2/IL-6/NF-&#x03BA;B/BMP-2/TGF-&#x03B2; were measured. The intestinal microbiota was analyzed via 16S rDNA sequencing. After FMT which induced by TENS, the improvement of ATFL injury rat was analyzed.</p>
</sec>
<sec>
<title>Results</title>
<p>After TENS treatment, compared with the model control group, the bio-mechanical, gait, bone mineral density (BMD), etc. parameters were elevated in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); the expression of NOD2/IL-6 decreased and the BMP-2/TGF-&#x03B2; increased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). The intestinal microbiota was altered, including increases in the abundances of <italic>Erysipelotrichaceae</italic>, <italic>Lachnospira</italic>, <italic>Eubacterium</italic>, <italic>Phascolarctobacterium</italic>, and <italic>Alloprevotella</italic>. After FMT, similar improvements were found in ATFL injury rats.</p>
</sec>
<sec>
<title>Conclusion</title>
<p>TENS ameliorated ATFL injury rat by regulating the NOD2/IL-6/NF-&#x03BA;B/BMP-2/TGF-&#x03B2; and changed the intestinal microbiota through the gut-joint axis. Dominant intestinal microbiota was associated with FMT and could improve ATFL injury rat.</p>
</sec>
</abstract>
<kwd-group>
<kwd>ankle sprain</kwd>
<kwd>anterior talo-fibular ligament (ATFL)</kwd>
<kwd>fecal microbiota transplantation (FMT)</kwd>
<kwd>intestinal microbiota</kwd>
<kwd>transcutaneous electrical nerve stimulation (TENS)</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">
<institution-wrap>
<institution>Joint Foundation of Department of Science and Technology of Yunnan Province</institution>
</institution-wrap>
</funding-source>
<award-id rid="sp1">202401AY070001-091</award-id>
<award-id rid="sp1">202201AY070001-225</award-id>
<award-id rid="sp1">202201AY070001-008</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">
<institution-wrap>
<institution>Applied Basic Research Foundation of Yunnan Province</institution>
<institution-id institution-id-type="doi" vocab="open-funder-registry" vocab-identifier="10.13039/open_funder_registry">10.13039/100007471</institution-id>
</institution-wrap>
</funding-source>
<award-id rid="sp2">2025AY07000000</award-id>
</award-group>
<funding-statement>The author(s) declared that financial support was received for this work and/or its publication. This study was supported by the Applied Basic Research Foundation of Yunnan Province (202501AT070594), the Joint Foundation of Department of Science and Technology of Yunnan Province (202201AY070001-008, 202201AY070001-225, and 202401AY070001-091).</funding-statement>
</funding-group>
<counts>
<fig-count count="5"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="35"/>
<page-count count="11"/>
<word-count count="8552"/>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Microorganisms in Vertebrate Digestive Systems</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<label>1</label>
<title>Introduction</title>
<p>The anterior talo-fibular ligament (ATFL) is one of the most important ligament structures of the ankle joint, and its main role is to maintain the stability of the ankle joint (<xref ref-type="bibr" rid="ref23">Rougereau et al., 2024</xref>). Most ATFL injuries are caused by sports-related sprains and chronic ankle instability (CAI), which are manifested mainly as anterolateral ankle pain, joint instability and intermittent swelling (<xref ref-type="bibr" rid="ref17">Mao et al., 2025</xref>). The treatment of ATFL injury mainly includes conservative treatment and surgical treatment. Conservative treatment means that first patients rest, walk with appropriate weight, gradually strengthen functional reconstruction, and finally strengthen the whole body to prevent recurrence (<xref ref-type="bibr" rid="ref24">Sethi et al., 2023</xref>). However, conservative treatment has a long cycle and is difficult for patients to recover from persistent synovitis or tendinitis, ankle swelling, pain, and muscle weakness (<xref ref-type="bibr" rid="ref21">Qin et al., 2025</xref>). At present, there are three widely used surgical treatments: the <italic>Brostr&#x00F6;m</italic> method, the <italic>Watson&#x2013;Jones</italic> method and ankle arthroscopy (<xref ref-type="bibr" rid="ref3">Chen et al., 2023</xref>). Surgical treatment can produce adequate clinical results, but it does not result in adequate strength and is unable to satisfy the requirements of high-demand activities (<xref ref-type="bibr" rid="ref13">Li et al., 2023</xref>).</p>
<p>Transcutaneous electrical nerve stimulation (TENS) is a non-injury-inducing treatment in which a specific low-frequency pulse current is applied into the human body through the skin to stimulate nerves for analgesia (<xref ref-type="bibr" rid="ref30">Vance et al., 2022</xref>). TENS has advantages including safety, good analgesic effects, ability to reduce the use of opioids and capacity to circumvent the risk of infectious diseases induced by acupuncture (<xref ref-type="bibr" rid="ref27">Szmit et al., 2023</xref>). TENS is a non-pharmacological intervention used to treat acute and chronic pain conditions in the clinic. There are two mechanisms of the analgesic effect of TENS: one relies on the gate control theory, and the other promotes the release of endogenous opioids, ultimately blocking the transmission of pain information to achieve pain relief (<xref ref-type="bibr" rid="ref4">Chimenti et al., 2018</xref>).</p>
<p>The intestinal microbiota is composed of microorganisms and their genomic components and products in the gastrointestinal tract and has a relatively stable population structure (<xref ref-type="bibr" rid="ref1">Altun et al., 2025</xref>). The microbiota is large in number and diverse. The human gut microbiota is composed of more than 100 trillion bacteria and more than 3 million unique genes, so the gut microbiota is called the &#x201C;second genome&#x201D; and &#x201C;second brain&#x201D; of the human body (<xref ref-type="bibr" rid="ref31">Wang et al., 2023</xref>). An unhealthy imbalance in the composition of the microbial community, called &#x201C;dysbiosis,&#x201D; is closely associated with various metabolic, inflammatory, and intestinal barrier impairments. Research has suggested that <italic>Bifidobacterium longum</italic> CBi0703 administered orally over a period of 12&#x202F;weeks decreased the number of cartilaginous lesions and decreased type II collagen degradation (<xref ref-type="bibr" rid="ref8">Henrotin et al., 2021</xref>). Microbial DNA could be detected in intra-articular tissue and intra-cartilage tissue in the ankle joint injury (<xref ref-type="bibr" rid="ref34">Zhao et al., 2018</xref>). Research has confirmed that some medicines have a positive effect on osteoarthritis by regulating the intestinal microbiota and serum metabolites (<xref ref-type="bibr" rid="ref9">Jie et al., 2023</xref>). Recovery from injury to the ATFL is difficult, and patients can easily develop CAI and ankle osteoarthritis.</p>
<p>In this study, the rat models of ATFL damage were generated in duplicate and treated with TENS. After 1, 2, and 3&#x202F;weeks of TENS treatment, the improvement of ATFL injury in rats was measured. Moreover, the osteogenic and anti-inflammatory effects of TENS in rats with ATFL injuries were analyzed. The intestinal microbiota of rats with ATFL injuries was subsequently analyzed via 16S rDNA sequencing. The ankle joint-gut axis was analyzed, and fecal microbiota transplantation (FMT) was performed using the dominant microbiota induced by TENS treatment in rats with ATFL injury. After 1, 2, or 3&#x202F;weeks of FMT, the improvement, osteogenic and anti-inflammatory effects of FMT in rats with ATFL injuries were analyzed.</p>
</sec>
<sec sec-type="materials|methods" id="sec2">
<label>2</label>
<title>Materials and methods</title>
<sec id="sec3">
<label>2.1</label>
<title>TENS</title>
<p>TENS setting range as follows: the voltage peak value from 0.75&#x2013;47.20 Vpp; the voltage values from 0.375&#x2013;23.600&#x202F;V; the current value 0.3675&#x2013;23.1280&#x202F;mA; the electric current density 0.1470&#x2013;9.2512&#x202F;A/m<sup>2</sup>; the frequency 25.00&#x202F;Hz; stimulating the inner and outer sides of the knee joint in rats.</p>
</sec>
<sec id="sec4">
<label>2.2</label>
<title>Animals</title>
<p>All animal experiments were approved by the Animal Study Committee of Kunming Medical University (No. KMMU2023MEC203) and were conducted according to the requirements of NIH Guidelines for care and use of laboratory animals. A total of 60 rats (Purchased from Kunming Medical University, Department of Animal, No. SYXK K2020-006), three-month-old SD female rats (200&#x202F;&#x00B1;&#x202F;10&#x202F;g) were maintained in standard conditions with a controlled temperature (21&#x2013;23&#x202F;&#x00B0;C) and a strict 12&#x202F;h light/dark cycle. All the rats were fed with standard rat chow and allowed free access to distilled water <italic>ad libitum</italic> at all times during acclimatization and experimental treatment periods.</p>
</sec>
<sec id="sec5">
<label>2.3</label>
<title>ATFL rat</title>
<p>Before the operation, fasting deprivation for 12&#x202F;h, water deprivation for 6&#x202F;h and the rats were anesthetized with intraperitoneal injection of sodium pentobarbital (0.1%, 35&#x202F;mg/kg; Merck Ltd., Germany). ATFL model was constructed by partial resection of the anterior talo-fibular ligament of the right ankle. After the operation, ampicillin (6,000&#x202F;IU/kg/day, HYZS Ltd., China) was injected intramuscularly for 3&#x202F;days.</p>
</sec>
<sec id="sec6">
<label>2.4</label>
<title>Grouping</title>
<p>A total of 36 ATFL rats were randomly divided into the model control (C) group, the low/medium/high (L/M/H) intensity of TENS group (low intensity: 3.16 Vpp, 1.58&#x202F;V, 1.55&#x202F;mA; medium intensity: 6.16 Vpp, 3.08&#x202F;V, 3.02&#x202F;mA; high intensity: 12.90 Vpp, 6.45&#x202F;V, 6.32&#x202F;mA) for 1/2/3&#x202F;weeks.</p>
<p>Then a total of 24 ATFL rats were divided into eight groups, including the model control (C) group and the low/medium/high (L/M/H) intensity of TENS group treated with TENS (manufactured FMT which induced by TENS) or treated with FMT for 3&#x202F;weeks.</p>
</sec>
<sec id="sec7">
<label>2.5</label>
<title>Intestinal sample collection</title>
<p>When the animal model (the weights were 226.00&#x2013;238.38&#x202F;g, 249.25&#x2013;255.00&#x202F;g, 240.75&#x2013;245.88&#x202F;g after 1, 2, 3&#x202F;weeks of induction) was euthanized by an overdose of anesthetic (150.0&#x202F;mg/kg sodium pentobarbital, i.m.), the judgement standard of death was pupils dilated, absence of light reflex, breathing and heartbeat cease according to the Guideline for ethical review of animal welfare in Chinese. The intestinal samples were collected from the colon bags, including ATFL.1/2/3W.C.1/2/3, ATFL.1/2/3W.L/M/H.1/2/3. All samples are placed in sterile PBS and analyzed with 16S rDNA sequencing (Novogene Ltd., China).</p>
</sec>
<sec id="sec8">
<label>2.6</label>
<title>16S rDNA sequencing</title>
<p>The intestinal samples were extracted by using the magnetic bead method of the Soil and Fecal Genomic cDNA Extraction Kit (TianGen, China) according to the manufacturer&#x2019;s instructions. The V4&#x2013;V5 region of the 16S rDNA gene was amplified by polymerase chain reaction (PCR) with a universal F&#x2032; and a unique bar-coded fusion R&#x2032; (341 F: ACTCCTACGGGAGGCAGCAG; 806 R: GGACTACHVGGGTWTCTAAT). Then, 15&#x202F;mL of Phusion<sup>&#x00AE;</sup> High-Fidelity PCR Master Mix (New England Biolabs), 0.2&#x202F;mM primers and 10&#x202F;ng of genomic DNA template was added to all PCR mixtures. The PCR conditions were as follows: denaturation at 98&#x202F;&#x00B0;C for 1&#x202F;min, followed by denaturation at 98&#x202F;&#x00B0;C for 10&#x202F;s, annealing at 50&#x202F;&#x00B0;C for 30&#x202F;s and extension at 72&#x202F;&#x00B0;C for 30&#x202F;s for a total of 30 cycles, and finally maintenance at 72&#x202F;&#x00B0;C for 5&#x202F;min. The amplicons were purified using AMPure beads (Axygen Co., United States). Barcoded libraries were generated by emulsion PCR and sequenced in the V4 to V5 reverse direction on a 318 chip using the 400&#x202F;bp sequencing kit of the Ion Torrent Personal Genome Machine (PGM Co., United States) system according to the manufacturer&#x2019;s instructions. The output sequences of each sample were no less than 50,000 pairs corresponding to 25,000 clean targets, and informatics methods (strategies: PE101/PE150/PE250/PE300, R language packages: QIIM2, ggplots) were applied.</p>
</sec>
<sec id="sec9">
<label>2.7</label>
<title>Preparation of FMT</title>
<p>Briefly, 12 ATFL rats were randomly selected and divided into the four groups as previously and treated with TENS for 3&#x202F;weeks as the donor rats. During the experimental cycle, the rats were induced to excrete fresh feces (3.0&#x202F;g) by anal stimulation method at 9&#x202F;a.m. of a day. Further sterile PBS was added, mixed and evenly dissolved (1:10), and vortex for about 0.5&#x202F;min until there were no visible fecal particles. The collected samples were centrifuged at 2,000&#x202F;rpm and 4&#x202F;&#x00B0;C for 10&#x202F;min and the fecal residue was discarded. Then the supernatant was centrifuged at 8,000&#x202F;rpm, 4&#x202F;&#x00B0;C for 5&#x202F;min to obtain total bacteria. 0.1&#x202F;mL of the diluted bacterial solution was cultured and calculated according to the formula viable count&#x202F;=&#x202F;average colony count&#x202F;&#x00D7;&#x202F;dilution ratio/dose volume. Finally, the 1&#x202F;mL bacterial suspension (10<sup>9</sup>&#x202F;CFU/mL) was transplanted to recipient rats one time per day for 3&#x202F;weeks and the model control group was given 1&#x202F;mL PBS. After the 3&#x202F;weeks treatment with FMT, the rats were conducted with fasting deprivation for 12&#x202F;h and the fecal samples were collected. The clearance of intestinal microbiota ahead of FMT with antibiotics metronidazole, neomycin C, ampicillin, vancomycin (50&#x202F;mg: 50&#x202F;mg: 50&#x202F;mg: 25&#x202F;mg diluted in 200&#x202F;mL PBS, 200&#x202F;&#x03BC;L/day per rat for 5&#x202F;days).</p>
</sec>
<sec id="sec10">
<label>2.8</label>
<title>Histopathological evaluation</title>
<p>The samples were harvested and fixed in 10% paraformaldehyde (Gefan Biotechnology Co., Ltd., China) for 14&#x202F;days, dehydrated and gradually decalcified. Five-micrometre-thick sections were prepared using a Leica RM2245 microtome and stained with Hematein and Eosin (HE), Alcian blue (AB) &#x0026; Alizarin red (Servicebio Co., China).</p>
</sec>
<sec id="sec11">
<label>2.9</label>
<title>Evaluation of the <italic>Mankin</italic> score</title>
<p>The <italic>Mankin</italic> score quantifies the extent of cartilage degeneration by assessing the structure, cell number, matrix staining, and tideline integrity of the cartilage. A higher <italic>Mankin</italic> score indicates more severe cartilage degeneration as follows:</p>
<list list-type="simple">
<list-item>
<p>Cartilage structure: 0 for normal, 1 for surface irregularity, 2 for pannus formation and surface irregularity, 3 for fissure into the transition layer, 4 for fissure into the radiation layer, 5 for fissure into the calcification layer, and 6 for complete structural destruction.</p>
</list-item>
<list-item>
<p>Chondrocytes: 0 for normal, 1 for diffuse increased cells, 2 for focal increased cells, and 3 for significantly reduced cell number.</p>
</list-item>
<list-item>
<p>Cartilage matrix staining: 0 for normal, 1 for mild reduction, 2 for moderate reduction, 3 for severe reduction, and 4 for no staining.</p>
</list-item>
<list-item>
<p>Tideline integrity: 0 for completeness and 1 for vascular disruption.</p>
</list-item>
</list>
</sec>
<sec id="sec12">
<label>2.10</label>
<title>Micro-computed tomography analysis</title>
<p>Micro-computed tomography (Micro-CT) analysis was performed according to recent guidelines<sup>56</sup> using a SkyScan 1176 micro-CT imaging system (SkyScan, Bruker Ltd., Belgium) with a spatial resolution of 17.75&#x202F;mm (X-ray source 70&#x202F;kV/357&#x202F;mA, 90&#x202F;kV/270&#x202F;mA; exposure time 250&#x202F;ms/360&#x202F;ms; magnification &#x00D7;15; and 1.0&#x202F;mm aluminum/0.1&#x202F;mm copper filter). Volumetric reconstructions and analyses were performed using the built-in software NRecon 1.6 and CTAn 1.8. For the analysis of bone regeneration, the volume of interest was measured by the average grayscale value at the specific bone position (minimum to maximum degree: 0&#x2013;255).</p>
</sec>
<sec id="sec13">
<label>2.11</label>
<title>Immunohistological analysis</title>
<p>The sample were equilibrated in 0.1 Mtris-buffered saline for 10&#x202F;min. After 1&#x202F;hour of blockage in phosphate buffered saline (PBS) with 10% normal goat serum, the samples were incubated overnight at 4&#x202F;&#x00B0;C with anti-bodies (NOD2, DF12125, 1:500, Affinity Co., China; IL-6, GB11117-50, 1:500, Servicebio Co., China). Then the samples were incubated with HRP-conjugated secondary antibody (GB23303, 1:500; Servicebio Co., China) for 1&#x202F;h at room temperature. The results were enumerated by the ImageJ software (National Institutes of Health, Bethesda, MD, United States).</p>
</sec>
<sec id="sec14">
<label>2.12</label>
<title>Step number of hind leg</title>
<p>The athletic ability of the ATFL rats was analyzed by calculating step number of hind leg which was recorded as the number of step number rats ran through a 25.00&#x202F;cm exercise wheel. The rats were observed once a day for 6&#x202F;days/week.</p>
</sec>
<sec id="sec15">
<label>2.13</label>
<title>Bone biomechanics</title>
<p>A sample of the ankle was taken to keep the ligament-bone junction intact. Before starting the measurement, the length, width and thickness need to be measured (Muromachi Co., Japan), and then after bathing and stretching the fitting with normal saline, the ankle are fixed on the MTS universal materials testing machine to measure compression, bending and tensile related data.</p>
</sec>
<sec id="sec16">
<label>2.14</label>
<title>AI gait analysis</title>
<p>Each rat was placed in a running wheel setup, where a camera recorded its movement at a frame rate of 30.00&#x202F;Hz for a duration of 1&#x202F;min. To ensure accurate tracking, key body parts were manually labeled in a set of key frames, including the knee (purple), ankle (cyan), and paw (red). The labeled dataset was used to train a deep learning model in DeepLabCut. Using a convolutional neural network, the model learned the spatial characteristics of each marker, enabling it to recognize and track these points in subsequent videos. Once trained, the model was applied to new videos for pose estimation and motion tracking, outputting coordinate data for each labeled body part. For analysis, the 1-min recording was divided into three 20-s segments. The following metrics were calculated for each segment:</p>
<list list-type="simple">
<list-item>
<p>Step length: Measured as the distance between successive placements of the paw marker.</p>
</list-item>
<list-item>
<p>Step frequency: Calculated based on the number of steps within each 20-s interval.</p>
</list-item>
<list-item>
<p>Ankle joint angle: Calculated as the angle formed between the knee and paw markers with the ankle as the vertex, providing insight into joint movement during running.</p>
</list-item>
</list>
</sec>
<sec id="sec17">
<label>2.15</label>
<title>Virus tracing</title>
<p>A scAAV2/1-hSyn-EGFP-WPRE-pA virus (S0581-1, Taitool Bioscience Co. China) was injected into the joint cavity of ATFL rats, and the working concentration was 0.44 E13 VG (virus genome)/60&#x202F;mL. After 3&#x202F;weeks of treatment with TENS, the colon was collected and sliced at a thickness of 8&#x202F;mm. Subsequently, the sections were analyzed with a microscope (Eclipse ci, NIS_F_Ver43000_64bit_E&#x0026;Digital sight DS-FI2, NIKON Co., Japan).</p>
</sec>
<sec id="sec18">
<label>2.16</label>
<title>Quantitative PCR</title>
<p><italic>IL-6</italic> (Rattus), F&#x2032; CACTTCACAAGTCGGAGGCT, R&#x2019; AGCACACTAGGTTTGCCGAG; <italic>NOD2</italic> (Rattus), F&#x2032; GCAAGCACTTCCACTCCATC, R&#x2032; CAACTTGAGGTGCCCAACAT; <italic>BMP-2</italic> (Rattus), F&#x2032; GAAAACAGCAGCAGTGACC, R&#x2032; GGTGGCGTTCATGTAGGAGT; <italic>TGF-&#x03B2;</italic> (Rattus), F&#x2032; TGGGCACTGCTAGAGCCTAT, R&#x2032; GCGGAGATCCATACAAAGGA; <italic>NF-&#x03BA;B</italic> (Rattus), F&#x2032; TGTGAAGAAGCGAGACCTGG, R&#x2032; TGCTCCTCTATGGGAACTTGAA. <italic>Erysipelotrichaceae</italic>, F&#x2032; GGCGTGGATATGGTAGTGGT, R&#x2032; TAGTTCGAGCTCTGGTCTGC; <italic>Lachnospira</italic>, F&#x2032; TCATGCCTCCATTAGTTGTAAGCCT, R&#x2032; ATGAAGACTAATAACTCCAAAGAAAAAGTACGACAAC; <italic>Eubacterium</italic>, F&#x2032; ATGTTCAACGTAGGCGACCTGA, R&#x2032; TCAGTCGACGGTTCGGTCG; <italic>Phascolarctobacterium</italic>, F&#x2032; AACACATGCAAGTCGAACGG, R&#x2032; TTTCTTCATCCTGCCATGCG; <italic>Alloprevotella</italic>, F&#x2032; GTGAAAGTTCGGGGCTCAAC, R&#x2032; TCAGCGTCAGTTACACTCCG; 16S rRNA, F&#x2032; GTGCCAGCMGCCGCGGTAA, R&#x2032; TACCGCGGCTGCTGGCAC.</p>
</sec>
<sec id="sec19">
<label>2.17</label>
<title>Western blot</title>
<p>The following antibodies were used: anti-GAPDH (GB15004, 1:5,000, Servicebio Co., China), anti-&#x03B2;-ACTIN (GB11001-100, 1:5,000, Servicebio Co., China), anti-BMP-2 (GB11252, 1:5,000, Servicebio Co., China), and anti-TGF-&#x03B2;1 (GB115750, 1:5,000, Servicebio Co., China), anti-NOD2 (DF12125, 1:5,000, Affinity Co., China), P65 (GB11997-100, 1:1,000, Servicebio Co., China).</p>
</sec>
<sec id="sec20">
<label>2.18</label>
<title>Statistical analysis</title>
<p>Data was analyzed by GraphPad Prism 8 software (GraphPad, San Diego, CA, United States) and presented as the form of mean&#x202F;&#x00B1;&#x202F;standard deviation (SD). The <italic>p</italic>-value of operational taxonomic unit (OTU) was performed by <italic>MetagenomeSeq test</italic>. The statistical differences were analyzed by <italic>one-way analysis of</italic> var<italic>iance (ANOVA)</italic> with <italic>Tukey&#x2019;s post-hoc test</italic> for multiple group comparisons (SPSS 27.0, United States), and <italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 indicated statistical significance.</p>
</sec>
</sec>
<sec sec-type="results" id="sec21">
<label>3</label>
<title>Results</title>
<sec id="sec22">
<label>3.1</label>
<title>TENS treatment improves the function and bone quality in rats with ATFL injuries</title>
<p>After 2 or 3&#x202F;weeks of treatment with TENS, compared with those in the model control group, the weights in the low and high-intensity TENS groups decreased (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1A</xref>). After 2&#x202F;weeks of treatment with TENS, compared with that in the model control group, the degree of swelling decreased in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1B</xref>). After 1&#x202F;week of treatment with TENS, the 25-cm step number increased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1C</xref>). After 3&#x202F;days of treatment with TENS, the degree of varus and valgus ankle angles decreased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figures 1D</xref>,<xref ref-type="fig" rid="fig1">E</xref>); the inclined plane test degrees increased in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1F</xref>). Compared with those before the ATFL operation, the average step length, step frequency, and average ankle angle degree decreased postoperatively (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1G</xref>). After 3&#x202F;weeks of treatment with TENS, compared with those in the model control group, the average step length and step frequency were greater in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figures 1H</xref>,<xref ref-type="fig" rid="fig1">I</xref>), and the average ankle angle was greater in the high-intensity TENS group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figure 1J</xref>). Compared with those in the model control group, the biomechanical distance, max power, and stiffiness were greater in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig1">Figures 1K</xref>&#x2013;<xref ref-type="fig" rid="fig1">M</xref>).</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>TENS treatment improves the function and bone quality in rats with ATFL injuries. <bold>(A)</bold> The weight of ATFL rats after 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(B)</bold> The ankle swelling degree of ATFL rats after 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(C)</bold> The step number of 25&#x202F;cm in ATFL rat after 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(D,E)</bold> The angle of varus and valgus ankle in ATFL rat after 1, 3&#x202F;days and 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(F)</bold> The degree of inclined plane test in ATFL rat after 1, 3&#x202F;days and 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(G&#x2013;J)</bold> The average step length, step frequency, average ankle angle of ATFL rat which analyzed by AI gait analysis after 1, 2, 3&#x202F;weeks of treatment with TENS. <bold>(K&#x2013;M)</bold> The bio-mechanical distance, max power, stiffness in ATFL rat after 1, 2, 3&#x202F;weeks of treatment with TENS. The values are presented as the mean&#x202F;&#x00B1;&#x202F;standard deviation. <sup>&#x002A;</sup><italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 vs. the model control group, <italic>n</italic>&#x202F;=&#x202F;3.</p>
</caption>
<graphic xlink:href="fmicb-17-1770614-g001.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Grouped bar and column charts labeled panels A through M show comparisons of functional and biomechanical measures across four groups: model control, low, medium, and high intensity of TENS over time, with color-coded legends. Individual data points and error bars are visible on all graphs, and axes represent various outcomes including weight, stride length, step frequency, ankle angle, stiffness, power, and other functional gait and mobility parameters at multiple time points pre- and post-operation.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec23">
<label>3.2</label>
<title>Osteogenesis and anti-inflammatory effects of TENS in rats with ATFL injury via regulation of the NOD2/IF-6/NF-&#x03BA;B and BMP2/TGF-&#x03B2; signaling pathways</title>
<p>Compared with that in the model control group, the bone mineral density (BMD) was greater in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figures 2A</xref>,<xref ref-type="fig" rid="fig2">B</xref>), the trabecular bone number (TB.n) value was greater in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05), and the structure model index (SMI) was greater in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). Compared with those of the model control group, the <italic>Mankin</italic> scores were lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figures 2C</xref>,<xref ref-type="fig" rid="fig2">D</xref>), the cartilage thicknesses were greater in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figure 2E</xref>), and the bone mass ratios were greater in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figure 2F</xref>). Compared with that in the model control group, which was analyzed by immunofluorescence (IF), NOD2 expression was lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figures 2G</xref>,<xref ref-type="fig" rid="fig2">H</xref>), and IL-6 expression was lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figures 2I</xref>,<xref ref-type="fig" rid="fig2">J</xref>). After 3&#x202F;weeks of treatment with TENS, compared with that in the model control group, NOD2 expression was lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figure 2K</xref>); BMP2 expression was greater in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); TGF-&#x03B2; expression was lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); and NF-&#x03BA;B expression was lower in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). Compared with that in the model control group, NOD2 expression was lower in the low and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig2">Figures 2L</xref>,<xref ref-type="fig" rid="fig2">M</xref>); BMP2 expression was greater in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); and NF-&#x03BA;B expression was lower in the high-intensity TENS group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05).</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Osteogenesis and anti-inflammatory effects of TENS in rats with ATFL injury via regulation of the NOD2/IF-6/NF-&#x03BA;B and BMP2/TGF-&#x03B2; signaling pathways. <bold>(A,B)</bold> The micro-CT results after 3&#x202F;weeks of treatment with TENS. <bold>(C&#x2013;F)</bold> The evaluation of <italic>Mankin</italic> score, cartilage thickness, and the ratio of bone mass by HE, Alcian blue, Alizarin red staining, and ImageJ analysis after 3&#x202F;weeks of treatment with TENS. The scale bar 100&#x202F;&#x03BC;m. <bold>(G,H)</bold> The NOD2 expressions which analyzed by IF and ImageJ after 3&#x202F;weeks of treatment with TENS. The NOD2 was green color and the scale bar 5000/100&#x202F;&#x03BC;m. <bold>(I,J)</bold> The IL-6 expressions which analyzed by IF and ImageJ after 3&#x202F;weeks of treatment with TENS. The IL-6 was red color and the scale bar 500/100&#x202F;&#x03BC;m. <bold>(K)</bold> The NOD2/BMP2/TGF-&#x03B2;/NF-&#x03BA;B expressions which analyzed by qPCR after 3&#x202F;weeks of treatment with TENS. The fold change (FC) was compared to the model control group (defined FC&#x202F;=&#x202F;1). <bold>(L,M)</bold> The NOD2/BMP2/TGF-&#x03B2;/NF-&#x03BA;B expressions which analyzed by WB after 3&#x202F;weeks of treatment with TENS. The index gray value vs. internal reference gray value represents the gray intensity ratio (%) which analyzed by ImageJ. The values are presented as the mean&#x202F;&#x00B1;&#x202F;standard deviation. <italic><sup>&#x002A;</sup>p</italic>&#x202F;&#x003C;&#x202F;0.05 vs. the model control group, <italic>n</italic>&#x202F;=&#x202F;3.</p>
</caption>
<graphic xlink:href="fmicb-17-1770614-g002.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel figure showing multiple experimental results comparing model control, low, medium, and high intensity of TENS. Includes micro-CT scans, histological images, immunofluorescence, bar graphs of quantified data, gene expression via PCR, and protein blots, each demonstrating differences among treatment groups.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec24">
<label>3.3</label>
<title>Changes in the intestinal OTUs of rats with ATFL injury after TENS treatment</title>
<p>After 3&#x202F;weeks of TENS treatment, the top 10 most abundant genera in rats with ATFL injury were selected (<xref ref-type="fig" rid="fig3">Figures 3A</xref>,<xref ref-type="fig" rid="fig3">B</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Figures 1A,B</xref>). After 3&#x202F;weeks of TENS treatment, compared with the C.3W.ATFL group, the top 10 genera of the TENS group with increased OTUs included <italic>Erysipelotrichaceae_UGG-003</italic>, <italic>Phascolarctobacterium</italic>, <italic>Alloprevotella</italic>, <italic>Eubacterium</italic>, and <italic>Lachnospiraceae_UCG-010</italic>; moreover, the genera with decreased OTUs included <italic>Candidatus_Soleaferrea</italic>, <italic>UCG-005</italic>, <italic>Rominococcacear</italic>, etc. (<xref ref-type="fig" rid="fig3">Figure 3C&#x2013;E</xref>; <xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1D</xref>). The top 11 representative sequences of the top 100 genera were obtained via multiple sequence alignment (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1C</xref>). Compared with those in the C.3W.ATFL group, the median, dispersion, maximum, and minimum values in the TENS groups were different in rats with ATFL injury after 3&#x202F;weeks of TENS treatment (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig3">Figure 3F</xref>). Compared with those in the C.3W.ATFL group, the unifrac distances were 0.164, 0.238, and 0.303, and the unweighted UniFrac distances were 0.374, 0.420, and 0.623 in the TENS groups (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figures 1E,F</xref>). The separation rates of PC1 and PC2 were 8.74 and 6.39%, respectively, as determined via principal component analysis (PCA; <xref ref-type="fig" rid="fig3">Figure 3G</xref>). There were obvious differences between the model groups and the TENS groups, and the separation rates of PC1 and PC2 were 37.82%/13.48 and 20.70%/9.77%, respectively, as determined via principal coordinate analysis (PCoA) (<xref ref-type="fig" rid="fig3">Figure 3H</xref>). According to the non-metric multidimensional scaling (NMDS) analysis results, the stresses of the samples were greater than 0.02 (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1G</xref>).</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Changes in the intestinal OTUs of ATFL rats after TENS treatment. <bold>(A)</bold> The species abundance clustering plot of groups at phylum level. <bold>(B)</bold> The species abundance clustering plot of groups at genus level. The abscissa is the sample name. The ordinate represents the relative abundance. <bold>(C&#x2013;E)</bold> The OTUs of ATFL rats after the treatment with L/M/H intensity of TENS. The ordinate is the absolute abundance of significantly divergent species. <bold>(F)</bold> Alpha diversity analysis of ATFL rats after TENS treatment. <bold>(G,H)</bold> The beta-diversities of all samples which analyzed by PCA, PCOA. The abscissa is one principal coordinate, the ordinate is the other principal coordinate. The closer the samples are, the more similar the species composition structure. Each point represented as a sample, and samples in the same group were represented as the same color. <bold>(I)</bold> The results of KO analysis level 1, 2, 3 which analyzed by PICRUST (Phylogenetic Investigation of Communities by Reconstruction of Unobserved States). The PICRUST functional analysis was based on KEGG database.</p>
</caption>
<graphic xlink:href="fmicb-17-1770614-g003.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel of scientific data visualizations related to microbial community analysis, including heatmaps comparing taxa abundances (A, B), boxplots showing relative abundances and diversity indices (C&#x2013;F), principal coordinates analysis scatter plots (G, H), and stacked bar charts of functional pathway distributions (I), with color coding distinguishing groups, phyla, and pathways.</alt-text>
</graphic>
</fig>
<p>After 3&#x202F;weeks of treatment with TENS, compared with those of the control model group, the top 10 functions of all of the groups increased metabolism, genetic information processing, and environmental information processing (among other actions) at level 1 (<xref ref-type="fig" rid="fig3">Figure 3I</xref>); moreover, the top 10 functions of all of the groups increased membrane transport, carbohydrate metabolism, replication and repair (among other actions) at level 2. The top 10 functions of all of the groups increased transporters, ABC transporters, general function prediction only (among other actions) (<xref ref-type="bibr" rid="ref25">Shi et al., 2023</xref>). The microbiota exhibiting changed abundances after treatment with TENS were related to each other, and the predicted functions worked in a cosynergistic manner (<xref rid="SM1" ref-type="supplementary-material">Supplementary Figure 1H</xref>).</p>
</sec>
<sec id="sec25">
<label>3.4</label>
<title>FMT which induce by TENS improves ankle function and bone quality via the gut-knee joint axis in ATFL rats</title>
<p>After 3&#x202F;weeks of treatment with TENS, the positive GFP fluorescence intensity of virus tracing increased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figures 4A</xref>,<xref ref-type="fig" rid="fig4">B</xref>); The FMT which induced by 3&#x202F;weeks of treatment with TENS was manufactured for ATFL rats and the dominant intestinal microbiota was analyzed by qPCR as the result of 16S rDNA analysis (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4C</xref>). After 2&#x202F;weeks of treatment with FMT, the weights in the medium/high intensity of TENS groups decreased compared to those of the model control group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4D</xref>). After 2&#x202F;weeks of treatment with FMT, compared with that in the model control group, the ankle swelling degrees decreased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4E</xref>). After 2&#x202F;weeks of treatment with FMT, the step number of 25&#x202F;cm increased in the low/medium intensity of TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4F</xref>). After treatment with FMT, the angle of varus and valgus ankle degree, the degree of inclined plane test was similar (<italic>p</italic>&#x202F;&#x003E;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figures 4G</xref>&#x2013;<xref ref-type="fig" rid="fig4">I</xref>). After ATFL operation, compared with the pre-op, the average step length, step frequency, degree of average ankle angle decreased in the post-op (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4J</xref>). After treatment with FMT, compared with that in the model control group, the average step length and step frequency was similar (<italic>p</italic>&#x202F;&#x003E;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figures 4K</xref>,<xref ref-type="fig" rid="fig4">L</xref>); after 2&#x202F;weeks of treatment with FMT, the average ankle angle increased in the medium/high TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figure 4M</xref>). After 3&#x202F;weeks of treatment with FMT, compared with that in the model control group, the bio-mechanical distance, max power, stiffiness increased in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig4">Figures 4N</xref>&#x2013;<xref ref-type="fig" rid="fig4">P</xref>).</p>
<fig position="float" id="fig4">
<label>Figure 4</label>
<caption>
<p>FMT which induce by TENS improves ankle function and bone quality via the gut-knee joint axis in rats with ATFL injuries. <bold>(A,B)</bold> The virus tracing of gut in ATFL rat was stained by IF after 3&#x202F;weeks of virus tracing. Positive GFP label was color green. <bold>(C)</bold> The intestinal microbiota expressions of FMT was analyzed by qPCR. The fold change (FC) was compared to the 16S rRNA (defined FC&#x202F;=&#x202F;1). <bold>(D)</bold> The weight of ATFL rats after 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(E)</bold> The ankle swelling degree of ATFL rats after 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(F)</bold> The step number of 25&#x202F;cm in ATFL rat after 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(G,H)</bold> The angle of varus and valgus ankle in ATFL rat after 1, 3&#x202F;days and 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(I)</bold> The degree of inclined plane test in ATFL rat after 1, 3&#x202F;days and 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(J&#x2013;M)</bold> The average step length, step frequency, average ankle angle of ATFL rat which analyzed by AI gait analysis after 1, 2, 3&#x202F;weeks of treatment with FMT. <bold>(N&#x2013;P)</bold> The bio-mechanical distance, max power, stiffness in ATFL rat after 1, 2, 3&#x202F;weeks of treatment with FMT. The values are presented as the mean&#x202F;&#x00B1;&#x202F;standard deviation. <sup>&#x002A;</sup><italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 vs. the model control group, <italic>n</italic>&#x202F;=&#x202F;3.</p>
</caption>
<graphic xlink:href="fmicb-17-1770614-g004.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Panel of scientific data including fluorescent microscopy images (panel A), bar graphs, and line graphs (panels B&#x2013;P) comparing model control and varying intensities of TENS treatment across several biological and behavioral metrics in a laboratory setting, each group color-coded for comparison.</alt-text>
</graphic>
</fig>
</sec>
<sec id="sec26">
<label>3.5</label>
<title>FMT induced by TENS improved ATFL injury in rats by regulating the NOD2/BMP2/TGF-&#x03B2; signaling pathway</title>
<p>Compared with those in the model control group, the BMD, bone mineral content (BMC), TB.n and trabecular bone thickness (TB.th) in the high-intensity TENS group increased after 3&#x202F;weeks of treatment with FMT (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5A</xref>,<xref ref-type="fig" rid="fig5">B</xref>). Compared with those in the model control group, the <italic>Mankin</italic> scores were lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5C</xref>,<xref ref-type="fig" rid="fig5">D</xref>), and the cartilage thickness and the ratio of bone mass were greater in the high-intensity TENS group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5E</xref>,<xref ref-type="fig" rid="fig5">F</xref>). Compared with that in the model control group, NOD2 expression was higher in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5G</xref>,<xref ref-type="fig" rid="fig5">H</xref>), and IL-6 expression was lower in the TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5I</xref>,<xref ref-type="fig" rid="fig5">J</xref>). After 3&#x202F;weeks of treatment with FMT, compared with that in the model control group, NOD2 expression was lower in the low and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figure 5K</xref>); BMP2 expression was greater in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); TGF-&#x03B2; expression was lower in the low and medium-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); and NF-&#x03BA;B expression was lower in the high-intensity TENS group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05). After 3&#x202F;weeks of FMT, compared with those in the model control group, NOD2 and BMP2 expression increased in the medium and high-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05, <xref ref-type="fig" rid="fig5">Figures 5L</xref>,<xref ref-type="fig" rid="fig5">M</xref>); TGF-&#x03B2; expression decreased in the low and medium-intensity TENS groups (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05); and NF-&#x03BA;B expression decreased in the high-intensity TENS group (<italic>p</italic>&#x202F;&#x003C;&#x202F;0.05).</p>
<fig position="float" id="fig5">
<label>Figure 5</label>
<caption>
<p>FMT induced by TENS improved ATFL injury in rats by regulating the NOD2/BMP2/TGF-&#x03B2; signaling pathway. <bold>(A,B)</bold> The micro-CT results after 3&#x202F;weeks of treatment with FMT. <bold>(C&#x2013;F)</bold> The evaluation of <italic>Mankin</italic> score, cartilage thickness, and the ratio of bone mass by HE, Alcian blue, Alizarin red staining, and ImageJ analysis after 3&#x202F;weeks of treatment with TENS. The scale bar 100&#x202F;&#x03BC;m. <bold>(G,H)</bold> The NOD2 expressions which analyzed by IF and ImageJ after 3&#x202F;weeks of treatment with TENS. The NOD2 was green color, and the scale bar 5,000/100&#x202F;&#x03BC;m. <bold>(I,J)</bold> The IL-6 expressions which analyzed by IF and ImageJ after 3&#x202F;weeks of treatment with FMT. The IL-6 was red color, and the scale bar 5,000/100&#x202F;&#x03BC;m. <bold>(K)</bold> The NOD2/BMP2/TGF-&#x03B2;/NF-&#x03BA;B expressions which analyzed by qPCR after 3&#x202F;weeks of treatment with FMT. The fold change (FC) was compared to the model control group (defined FC&#x202F;=&#x202F;1). <bold>(L,M)</bold> The NOD2/BMP2/TGF-&#x03B2;/NF-&#x03BA;B expressions which analyzed by WB after 3&#x202F;weeks of treatment with FMT. The index gray value vs. internal reference gray value represents the gray intensity ratio (%) which analyzed by ImageJ. The values are presented as the mean&#x202F;&#x00B1;&#x202F;standard deviation. <sup>&#x002A;</sup><italic>p</italic>&#x202F;&#x003C;&#x202F;0.05 vs. the model control group, <italic>n</italic>&#x202F;=&#x202F;3.</p>
</caption>
<graphic xlink:href="fmicb-17-1770614-g005.tif" mimetype="image" mime-subtype="tiff">
<alt-text content-type="machine-generated">Figure contains multiple panels displaying scientific data comparing model control with low, medium, and high intensity TENS treatments. Panels include CT scans of joints (A), quantitative bar graphs with colored bars and statistical markers (B, D, E, F, H, J, K, M), histological tissue stain images (C), two sets of fluorescence-stained tissue images (G, I), and a western blot analysis with corresponding protein bands (L). Each analysis visually assesses changes across experimental groups to illustrate differences in tissue structure and molecular marker expression.</alt-text>
</graphic>
</fig>
</sec>
</sec>
<sec sec-type="discussion" id="sec27">
<label>4</label>
<title>Discussion</title>
<p>This study revealed the improvement of ATFL injury in rats via TENS, and its mechanism was related to osteogenesis and anti-inflammatory effects on the basis of surgery that is considered the gold standard for ATFL injury treatment. After TENS treatment, the body weights in the low and high-intensity TENS group decreased, and the body weights were better for surgical management (<xref ref-type="bibr" rid="ref18">Miranda et al., 2024</xref>); the degree of ankle swelling decreased in the TENS groups, indicating that TENS could at least improve swelling in rats with ATFL injury. As mentioned above, TENS is analgesic and anti-inflammatory after surgery (<xref ref-type="bibr" rid="ref12">Lee et al., 2024</xref>). The rats with ATFL injury in the TENS groups presented better motor ability in this study. An AI gait method of analyses motor ability in terms of step length, frequency and ankle degree. Some automated methods, such as gait analysis and deep learning, have been used in the diagnosis of ATFL injury (<xref ref-type="bibr" rid="ref19">Ni et al., 2023</xref>). Moreover, the biomechanical indices of rats with ATFL injury improved after TENS treatment. A study revealed that quantitatively evaluating the biomechanical effects of ATFL and CFL lesions could aid in the repair of ATFL injury, and a better biomechanical structure improved the stability of the ankle (<xref ref-type="bibr" rid="ref11">Larkins et al., 2021</xref>). Moreover, the results of this study revealed better microstructures in the TENS groups than in the model control group. TENS increased the micro-CT index, cartilage thickness, and bone mass and decreased the <italic>Mankin</italic> score in rats with ATFL injury. A simple validation experiment revealed the anti-inflammatory effects of TENS in rats with ATFL injury via the downregulation of IF-6/NF-&#x03BA;B expression, as described in previous research. The improvement in bone quality in the TENS groups was related to the regulation of NOD2/BMP2/TGF-&#x03B2; signaling. The experimental design was flawed, and we cannot explain why NOD2/BMP2/TGF-&#x03B2; signaling was dysregulated after TENS treatment. A related-omics study by our group revealed the NOD2/BMP2/TGF-&#x03B2; signaling pathway. Decreasing the expression of NOD2 could increase ALP secretion by primary osteoblasts in high-glucose medium (<xref ref-type="bibr" rid="ref2">Chen et al., 2024</xref>). NOD2, a member of the NOD-like receptor family of PRRs, is an important mediator of ER stress-induced inflammation in mouse and human cells. The ER stress inducers thapsigargin and dithiothreitol trigger the production of the proinflammatory cytokine IL-6 in a NOD1/2-dependent fashion via the NF-&#x03BA;B pathway (<xref ref-type="bibr" rid="ref10">Keestra-Gounder et al., 2016</xref>). BMP2, a pluripotent factor, is a member of the TGF-&#x03B2; super-family. It is a classic BMP2/TGF-&#x03B2; signaling pathway whose function is related to bone formation and an increase in the number of articular chondrocytes (<xref ref-type="bibr" rid="ref32">Yang et al., 2024</xref>). A study revealed that NOD2 expression deficiency promoted cardiac hypertrophy and fibrosis; it enhanced the activation of the NF-&#x03BA;B and TGF-&#x03B2;/Smad pathways in NOD2-knockout mice which compared with WT mice (<xref ref-type="bibr" rid="ref35">Zong et al., 2013</xref>). In summary, TENS activated NOD2 to ablate the anti-inflammatory effects of IF-6/NF-&#x03BA;B; meanwhile, TENS activated the BMP2/TGF-&#x03B2; pathway. An interesting finding related to ATFL and FMT was presented. After 3&#x202F;weeks of FMT, NOD2 protein expression, as well as BMP2 protein expression, increased in the medium and high-intensity TENS groups. We speculate that TENS could improve ATFL injury through the regulation of the NOD2/IF-6/NF-&#x03BA;B/BMP2/TGF-&#x03B2; signaling pathway. However, the expression of NOD2 increased in the TENS group and NF-&#x03BA;B decreased in the high intensity of TENS group after FMT. FMT induced by TENS could affect the regulation of ATFL injury rats via multiple repetitions and the exclusion of interfering factors.</p>
<p>The intestinal microbiota of rats with ATFL injury was analyzed via 16S rDNA sequencing after 1, 2, or 3&#x202F;weeks of treatment with TENS. In this study, we performed a sequential analysis of the changes in the intestinal microbiota, and these changes were not accidental. Several dominant genera affected the improvement of ATFL injury. First, the ankle joint-gut axis was confirmed in this study. The intestinal microbiota produces a variety of compounds that move from the &#x201C;leaky gut&#x201D; to the bloodstream, thereby leading to joint disease (<xref ref-type="bibr" rid="ref16">Longo et al., 2024</xref>). ATFL injury is closely related to the imbalance of the intestinal microbiota, and the ATFL injuries in rats were artificially induced in this study. Five dominant genera were <italic>Erysipelotrichaceae</italic>, <italic>Alloprevotella</italic>, <italic>Eubacterium</italic>, <italic>Lachnospiraceae</italic>, and <italic>Phascolarctobacterium</italic> in rats with ATFL injury after 3&#x202F;weeks of treatment with TENS. <italic>Erysipelotrichaceae</italic> might affect intestinal diseases, lung cancer, depression, etc. A study found that the change of <italic>Erysipelotrichaceae</italic> could affect the systemic immunity and inflammatory responses in a amyotrophic lateral sclerosis rats model; its regulation was related to the metabolites especially the levels of short and medium-chain fatty acids (<xref ref-type="bibr" rid="ref20">Niccolai et al., 2024</xref>). NOD2 is an intracellular PRR that senses bacterial peptidoglycan in the cytosol, and <italic>Erysipelotrichaceae</italic> increases the risk of inflammatory bowel disease (<xref ref-type="bibr" rid="ref28">Turpin et al., 2020</xref>). If a oral bacteria infection duplicated in the C57Bl/6 mouse, the alveolar bone loss was been found and the changed intestinal micriobiota were <italic>Erysipelotrichaceae</italic>, <italic>Alloprevotella</italic>, <italic>Rothia</italic> (<xref ref-type="bibr" rid="ref22">Rocha et al., 2024</xref>). <italic>Alloprevotella</italic> could become an oral biomarker to diagnose the intestinal metaphase phase of gastric patients, and it improved gut microbiota dysbiosis in obese mice fed a high-fat or high-sucrose diet (<xref ref-type="bibr" rid="ref14">Liu et al., 2023</xref>). <italic>Alloprevotella</italic> exhibited a positive correlation with the baseline level of serum phosphorus in patients who suffered from bone loss (<xref ref-type="bibr" rid="ref6">Coskun et al., 2024</xref>). Many studies have focused on energy homeostasis, colonic motility, immunomodulation and the suppression of inflammation by <italic>Eubacterium</italic> (<xref ref-type="bibr" rid="ref25">Shi et al., 2023</xref>). <italic>Lachnospiraceae</italic> belong to the core of the gut microbiota and are among the main producers of short-chain fatty acids (<xref ref-type="bibr" rid="ref29">Vacca et al., 2020</xref>). <italic>Phascolarctobacterium</italic> can produce short-chain fatty acids, and a gradual increase in the number of bacteria is maintained at a high level with increasing age (<xref ref-type="bibr" rid="ref5">Ciob&#x00E2;rc&#x0103; et al., 2025</xref>). Studies have shown that <italic>Phascolarctobacterium</italic> is related to neurological and psychiatric diseases (<xref ref-type="bibr" rid="ref33">Zang et al., 2023</xref>). In this study, these intestinal microbiota and their metabolic components, including genetic information processing, environmental information processing, and membrane transport, participated in the progression of ATFL injury. Currently, it exists no direct evidence to clarify the mechanism through which the microbiota facilitates osteogenesis and exerts anti-inflammatory effects; now, we did the research to reveal relationship between the intestinal micirobiota, metabolites, bone disease and it could bring a new perspectives for treating the KOA. Although osteogenesis was activated subsequent to TENS, it is hypothesized that the ligament condition of ATFL injury in rats was not repaired; and the improvement was contingent upon anti-inflammatory effects, enhanced local bone microstructure, and increased cartilage thickness, among other factors. A research report indicated that the <italic>Lactiplantibacillus</italic> plantarum EIR/IF-1 strain demonstrated a regulatory effects on the inflammatory response to lipopolysaccharide stimulation, cell migration, cell proliferation, and collagen synthesis in human periodontal ligament mesenchymal stromal cells (<xref ref-type="bibr" rid="ref7">Demirhan et al., 2025</xref>).</p>
<p>To verify the effects of the dominant genera on improving ATFL injury in rats, fecal microbiota transplantation (FMT), which was induced by different stimulated TENS, was used. FMT involves the transfer of stool from a healthy donor into the colon of a patient with the goal of restoring the normal microbiota and thus curing the disease (<xref ref-type="bibr" rid="ref15">Logo&#x0144; et al., 2023</xref>). In this study we manufactured four FMTs (one from control rats with ATFL injury; three were from rats subjected to different intensities of TENS) and treated rats with ATFL injuries for 3&#x202F;weeks. Similar results were obtained, and FMT induced by TENS improved ATFL injury. However, improvements in the results of the behavioural analysis were not apparent over a short period of treatment. A study of FMT and obesity lasted for 12&#x202F;weeks, and its treatment took into account the clinical disease (<xref ref-type="bibr" rid="ref26">Sivalingam et al., 2021</xref>). The experimental terminus was set 3&#x202F;weeks after TENS or FMT because ATFL injury patients who did not undergo surgery showed significant improvement in inflammation after 3&#x202F;weeks. The improvements related to FMT may have occurred later than those related to TENS, and FMT is a long-term treatment. The regulation of NOD2/IF-6/NF-&#x03BA;B and BMP2/TGF-&#x03B2; could provide insight into the mechanism of TENS and FMT for ATFL injury. TENS can regulate these gene targets, and its induced dominant genus also regulates these gene targets. Although TENS and FMT could improve ATFL injury via the ankle joint-gut axis, we still do not know that certain FMT compounds target NOD2 expression and promote osteogenesis and anti-inflammatory effects. The regulation of FMT is complicated, and it is necessary to analyse the contents of the intestinal microbiota in future studies.</p>
</sec>
<sec sec-type="conclusions" id="sec28">
<label>5</label>
<title>Conclusion</title>
<p>TENS improved ATFL injury in rats, and its mechanism of osteogenic and anti-inflammatory effects was related to the regulation of the NOD2/IF-6/NF-&#x03BA;B and BMP2/TGF-&#x03B2; signaling pathways. TENS can change the intestinal microbiota via the ankle joint-gut axis, and FMT induced by TENS can also improve ATFL injury in rats. TENS, which can induce FMT, even compounds the dominant genus, has the potential to treat ATFL injury in the clinic.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec29">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found at: 10.17632/nbzb98ks3x.1.</p>
</sec>
<sec sec-type="ethics-statement" id="sec30">
<title>Ethics statement</title>
<p>The animal study was approved by the Animal Experimental Ethical Committee of Kunming Medical University (No. KMMU2023MEC203). The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec sec-type="author-contributions" id="sec31">
<title>Author contributions</title>
<p>NC: Conceptualization, Methodology, Project administration, Data curation, Writing &#x2013; original draft. TM: Conceptualization, Data curation, Methodology, Writing &#x2013; original draft. RC: Methodology, Writing &#x2013; original draft. YZ: Writing &#x2013; original draft, Methodology. XT: Writing &#x2013; original draft, Methodology. YS: Conceptualization, Project administration, Writing &#x2013; review &#x0026; editing, Writing &#x2013; original draft, Funding acquisition.</p>
</sec>
<sec sec-type="COI-statement" id="sec32">
<title>Conflict of interest</title>
<p>The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec33">
<title>Generative AI statement</title>
<p>The author(s) declared that Generative AI was not used in the creation of this manuscript.</p>
<p>Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.</p>
</sec>
<sec sec-type="disclaimer" id="sec34">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec sec-type="supplementary-material" id="sec35">
<title>Supplementary material</title>
<p>The Supplementary material for this article can be found online at: <ext-link xlink:href="https://www.frontiersin.org/articles/10.3389/fmicb.2026.1770614/full#supplementary-material" ext-link-type="uri">https://www.frontiersin.org/articles/10.3389/fmicb.2026.1770614/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Supplementary_file_1.docx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Altun</surname><given-names>M.</given-names></name> <name><surname>K&#x00FC;&#x00E7;&#x00FC;k</surname><given-names>U.</given-names></name> <name><surname>Y&#x0131;ld&#x0131;r&#x0131;m</surname><given-names>N.</given-names></name></person-group> (<year>2025</year>). <article-title>Modulation of gut microbiota using VSL#3 and its impact on aortic parameters in a rat model</article-title>. <source>Anatol. J. Cardiol.</source> <volume>29</volume>, <fpage>282</fpage>&#x2013;<lpage>290</lpage>. doi: <pub-id pub-id-type="doi">10.14744/AnatolJCardiol.2025.5048</pub-id>, <pub-id pub-id-type="pmid">40114628</pub-id></mixed-citation></ref>
<ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Y. Y.</given-names></name> <name><surname>Tan</surname><given-names>L.</given-names></name> <name><surname>Su</surname><given-names>X. L.</given-names></name> <name><surname>Chen</surname><given-names>N. X.</given-names></name> <name><surname>Liu</surname><given-names>Q.</given-names></name> <name><surname>Feng</surname><given-names>Y. Z.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>NOD2 contributes to <italic>Parvimonas micra</italic>-induced bone resorption in diabetic rats with experimental periodontitis</article-title>. <source>Mol. Oral Microbiol.</source> <volume>39</volume>, <fpage>446</fpage>&#x2013;<lpage>460</lpage>. doi: <pub-id pub-id-type="doi">10.1111/omi.12467</pub-id>, <pub-id pub-id-type="pmid">38757737</pub-id></mixed-citation></ref>
<ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>R. P.</given-names></name> <name><surname>Wang</surname><given-names>Q. H.</given-names></name> <name><surname>Li</surname><given-names>M. Y.</given-names></name> <name><surname>Su</surname><given-names>X. F.</given-names></name> <name><surname>Wang</surname><given-names>D. Y.</given-names></name> <name><surname>Liu</surname><given-names>X. H.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Progress in diagnosis and treatment of acute injury to the anterior talofibular ligament</article-title>. <source>World J. Clin. Cases</source> <volume>11</volume>, <fpage>3395</fpage>&#x2013;<lpage>3407</lpage>. doi: <pub-id pub-id-type="doi">10.12998/wjcc.v11.i15.3395</pub-id>, <pub-id pub-id-type="pmid">37383912</pub-id></mixed-citation></ref>
<ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chimenti</surname><given-names>R. L.</given-names></name> <name><surname>Frey-Law</surname><given-names>L. A.</given-names></name> <name><surname>Sluka</surname><given-names>K. A.</given-names></name></person-group> (<year>2018</year>). <article-title>A mechanism-based approach to physical therapist management of pain</article-title>. <source>Phys. Ther.</source> <volume>98</volume>, <fpage>302</fpage>&#x2013;<lpage>314</lpage>. doi: <pub-id pub-id-type="doi">10.1093/ptj/pzy030</pub-id>, <pub-id pub-id-type="pmid">29669091</pub-id></mixed-citation></ref>
<ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ciob&#x00E2;rc&#x0103;</surname><given-names>D.</given-names></name> <name><surname>C&#x0103;toi</surname><given-names>A. F.</given-names></name> <name><surname>Gavrila&#x0219;</surname><given-names>L.</given-names></name> <name><surname>Banc</surname><given-names>R.</given-names></name> <name><surname>Miere</surname><given-names>D.</given-names></name> <name><surname>Filip</surname><given-names>L.</given-names></name></person-group> (<year>2025</year>). <article-title>Natural bioactive compounds in the management of type 2 diabetes and metabolic (dysfunction)-associated steatotic liver disease</article-title>. <source>Pharmaceuticals</source> <volume>18</volume>:<fpage>279</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ph18020279</pub-id>, <pub-id pub-id-type="pmid">40006091</pub-id></mixed-citation></ref>
<ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coskun</surname><given-names>M.</given-names></name> <name><surname>Babayeva</surname><given-names>A.</given-names></name> <name><surname>Barlas</surname><given-names>T.</given-names></name> <name><surname>Muhittin Yalcin</surname><given-names>M.</given-names></name> <name><surname>Akturk</surname><given-names>M.</given-names></name> <name><surname>Balos Toruner</surname><given-names>F.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Relationship between gut microbiome and bone deficits in primary hyperparathyroidism: a proof-of-concept pilot study</article-title>. <source>J. Investig. Med.</source> <volume>72</volume>, <fpage>541</fpage>&#x2013;<lpage>552</lpage>. doi: <pub-id pub-id-type="doi">10.1177/10815589241251695</pub-id>, <pub-id pub-id-type="pmid">38641855</pub-id></mixed-citation></ref>
<ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Demirhan</surname><given-names>H. K.</given-names></name> <name><surname>Omer Oglou</surname><given-names>E.</given-names></name> <name><surname>Aksoy</surname><given-names>Z. B.</given-names></name> <name><surname>Kiran</surname><given-names>F.</given-names></name></person-group> (<year>2025</year>). <article-title>Evaluation of the anti-inflammatory, antioxidant and regenerative effects of microbiota-derived postbiotics in human periodontal ligament mesenchymal stromal cells</article-title>. <source>Clin. Oral Investig.</source> <volume>29</volume>:<fpage>262</fpage>. doi: <pub-id pub-id-type="doi">10.1007/s00784-025-06341-1</pub-id>, <pub-id pub-id-type="pmid">40263129</pub-id></mixed-citation></ref>
<ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Henrotin</surname><given-names>Y.</given-names></name> <name><surname>Patrier</surname><given-names>S.</given-names></name> <name><surname>Pralus</surname><given-names>A.</given-names></name> <name><surname>Roche</surname><given-names>M.</given-names></name> <name><surname>Nivoliez</surname><given-names>A.</given-names></name></person-group> (<year>2021</year>). <article-title>Protective actions of oral administration of <italic>Bifidobacterium longum</italic> CBi0703 in spontaneous osteoarthritis in Dunkin Hartley guinea pig model</article-title>. <source>Cartilage</source> <volume>13</volume>, <fpage>1204S</fpage>&#x2013;<lpage>1213S</lpage>. doi: <pub-id pub-id-type="doi">10.1177/1947603519841674</pub-id>, <pub-id pub-id-type="pmid">30982336</pub-id></mixed-citation></ref>
<ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jie</surname><given-names>L.</given-names></name> <name><surname>Ma</surname><given-names>Z.</given-names></name> <name><surname>Gao</surname><given-names>Y.</given-names></name> <name><surname>Shi</surname><given-names>X.</given-names></name> <name><surname>Yu</surname><given-names>L.</given-names></name> <name><surname>Mao</surname><given-names>J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>The mechanism of palmatine-mediated intestinal flora and host metabolism intervention in OA-OP comorbidity rats</article-title>. <source>Front. Med.</source> <volume>10</volume>:<fpage>1153360</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2023.1153360</pub-id>, <pub-id pub-id-type="pmid">37153081</pub-id></mixed-citation></ref>
<ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keestra-Gounder</surname><given-names>A. M.</given-names></name> <name><surname>Byndloss</surname><given-names>M. X.</given-names></name> <name><surname>Seyffert</surname><given-names>N.</given-names></name> <name><surname>Young</surname><given-names>B. M.</given-names></name> <name><surname>Ch&#x00E1;vez-Arroyo</surname><given-names>A.</given-names></name> <name><surname>Tsai</surname><given-names>A. Y.</given-names></name> <etal/></person-group>. (<year>2016</year>). <article-title>NOD1 and NOD2 signaling links ER stress with inflammation</article-title>. <source>Nature</source> <volume>532</volume>, <fpage>394</fpage>&#x2013;<lpage>397</lpage>. doi: <pub-id pub-id-type="doi">10.1038/nature17631</pub-id>, <pub-id pub-id-type="pmid">27007849</pub-id></mixed-citation></ref>
<ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Larkins</surname><given-names>C. G.</given-names></name> <name><surname>Brady</surname><given-names>A. W.</given-names></name> <name><surname>Aman</surname><given-names>Z. S.</given-names></name> <name><surname>Dornan</surname><given-names>G. J.</given-names></name> <name><surname>Haytmanek</surname><given-names>C. T.</given-names></name> <name><surname>Clanton</surname><given-names>T. O.</given-names></name></person-group> (<year>2021</year>). <article-title>Evaluation of the intact anterior talofibular and calcaneofibular ligaments, injuries, and repairs with and without augmentation: a biomechanical robotic study</article-title>. <source>Am. J. Sports Med.</source> <volume>49</volume>, <fpage>2432</fpage>&#x2013;<lpage>2438</lpage>. doi: <pub-id pub-id-type="doi">10.1177/03635465211018645</pub-id>, <pub-id pub-id-type="pmid">34110933</pub-id></mixed-citation></ref>
<ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>T. Y.</given-names></name> <name><surname>Chen</surname><given-names>P. Y.</given-names></name> <name><surname>Yang</surname><given-names>K. C.</given-names></name> <name><surname>Tzeng</surname><given-names>I. S.</given-names></name> <name><surname>Ming Chang</surname><given-names>C.</given-names></name> <name><surname>Wang</surname><given-names>C. C.</given-names></name></person-group> (<year>2024</year>). <article-title>Comparison of knot-tying techniques during the arthroscopic Brostr&#x00F6;m-Gould procedure: semiconstrained freehand versus knot pusher techniques</article-title>. <source>Orthop. J. Sports Med.</source> <volume>12</volume>:<fpage>23259671231218649</fpage>. doi: <pub-id pub-id-type="doi">10.1177/23259671231218649</pub-id>, <pub-id pub-id-type="pmid">38274016</pub-id></mixed-citation></ref>
<ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Q.</given-names></name> <name><surname>Fu</surname><given-names>X.</given-names></name> <name><surname>Kou</surname><given-names>Y.</given-names></name> <name><surname>Han</surname><given-names>N.</given-names></name></person-group> (<year>2023</year>). <article-title>Engineering strategies and optimized delivery of exosomes for theranostic application in nerve tissue</article-title>. <source>Theranostics</source> <volume>13</volume>, <fpage>4266</fpage>&#x2013;<lpage>4286</lpage>. doi: <pub-id pub-id-type="doi">10.7150/thno.84971</pub-id>, <pub-id pub-id-type="pmid">37554270</pub-id></mixed-citation></ref>
<ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y.</given-names></name> <name><surname>Wang</surname><given-names>H.</given-names></name> <name><surname>Jiang</surname><given-names>H.</given-names></name> <name><surname>Sun</surname><given-names>Z.</given-names></name> <name><surname>Sun</surname><given-names>A.</given-names></name></person-group> (<year>2023</year>). <article-title>Alloprevotella can be considered as a potential oral biomarker in intestinal metaphase of gastric patients</article-title>. <source>Stud. Health Technol. Inform.</source> <volume>308</volume>, <fpage>155</fpage>&#x2013;<lpage>167</lpage>. doi: <pub-id pub-id-type="doi">10.3233/SHTI230836</pub-id>, <pub-id pub-id-type="pmid">38007737</pub-id></mixed-citation></ref>
<ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Logo&#x0144;</surname><given-names>K.</given-names></name> <name><surname>&#x015A;wirkosz</surname><given-names>G.</given-names></name> <name><surname>Nowak</surname><given-names>M.</given-names></name> <name><surname>Wrze&#x015B;niewska</surname><given-names>M.</given-names></name> <name><surname>Szczygie&#x0142;</surname><given-names>A.</given-names></name> <name><surname>Gomu&#x0142;ka</surname><given-names>K.</given-names></name></person-group> (<year>2023</year>). <article-title>The role of the microbiome in the pathogenesis and treatment of asthma</article-title>. <source>Biomedicine</source> <volume>11</volume>:<fpage>1618</fpage>. doi: <pub-id pub-id-type="doi">10.3390/biomedicines11061618</pub-id>, <pub-id pub-id-type="pmid">37371713</pub-id></mixed-citation></ref>
<ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Longo</surname><given-names>U. G.</given-names></name> <name><surname>Lalli</surname><given-names>A.</given-names></name> <name><surname>Bandini</surname><given-names>B.</given-names></name> <name><surname>de Sire</surname><given-names>R.</given-names></name> <name><surname>angeletti</surname><given-names>S.</given-names></name> <name><surname>Lustig</surname><given-names>S.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Role of the gut microbiota in osteoarthritis, rheumatoid arthritis, and spondylarthritis: an update on the gut-joint axis</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume>:<fpage>3242</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms25063242</pub-id>, <pub-id pub-id-type="pmid">38542216</pub-id></mixed-citation></ref>
<ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>W.</given-names></name> <name><surname>Jin</surname><given-names>Z.</given-names></name> <name><surname>Li</surname><given-names>W.</given-names></name> <name><surname>Zhu</surname><given-names>Y.</given-names></name> <name><surname>Kong</surname><given-names>W.</given-names></name> <name><surname>Wang</surname><given-names>Y.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>All-inside arthroscopic repair of ATFL and CFL separately for chronic lateral ankle instability in conjunction with subtalar instability</article-title>. <source>J. Orthop. Surg. Res.</source> <volume>20</volume>:<fpage>380</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s13018-025-05780-6</pub-id>, <pub-id pub-id-type="pmid">40234894</pub-id></mixed-citation></ref>
<ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miranda</surname><given-names>S.</given-names></name> <name><surname>Harahap</surname><given-names>A.</given-names></name> <name><surname>Husada</surname><given-names>D.</given-names></name> <name><surname>Faramarisa</surname><given-names>F. N.</given-names></name></person-group> (<year>2024</year>). <article-title>Risk factors of multidrug-resistant organisms neonatal sepsis in Surabaya tertiary referral hospital: a single-center study</article-title>. <source>BMC Pediatr.</source> <volume>24</volume>:<fpage>153</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12887-024-04639-9</pub-id>, <pub-id pub-id-type="pmid">38424519</pub-id></mixed-citation></ref>
<ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>M.</given-names></name> <name><surname>Chen</surname><given-names>W.</given-names></name> <name><surname>Zhao</surname><given-names>Q.</given-names></name> <name><surname>Zhao</surname><given-names>Y.</given-names></name> <name><surname>Yuan</surname><given-names>H.</given-names></name></person-group> (<year>2023</year>). <article-title>Deep learning approach for MRI in the classification of anterior talofibular ligament injuries</article-title>. <source>J. Magn. Reson. Imaging</source> <volume>58</volume>, <fpage>1544</fpage>&#x2013;<lpage>1556</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jmri.28649</pub-id>, <pub-id pub-id-type="pmid">36807381</pub-id></mixed-citation></ref>
<ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niccolai</surname><given-names>E.</given-names></name> <name><surname>Di Gloria</surname><given-names>L.</given-names></name> <name><surname>Trolese</surname><given-names>M. C.</given-names></name> <name><surname>Fabbrizio</surname><given-names>P.</given-names></name> <name><surname>Baldi</surname><given-names>S.</given-names></name> <name><surname>Nannini</surname><given-names>G.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Host genetics and gut microbiota influence lipid metabolism and inflammation: potential implications for ALS pathophysiology in SOD1G93A mice</article-title>. <source>Acta Neuropathol. Commun.</source> <volume>12</volume>:<fpage>174</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40478-024-01877-x</pub-id>, <pub-id pub-id-type="pmid">39506789</pub-id></mixed-citation></ref>
<ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Q. N.</given-names></name> <name><surname>Zhang</surname><given-names>X.</given-names></name> <name><surname>Cai</surname><given-names>Y. F.</given-names></name> <name><surname>Tian</surname><given-names>T. Z.</given-names></name> <name><surname>Zhou</surname><given-names>J. P.</given-names></name> <name><surname>Li</surname><given-names>L.</given-names></name> <etal/></person-group>. (<year>2025</year>). <article-title>Heel kicking exercise rapidly improves pain and function in patients with acute lateral ankle sprain: a randomized controlled trial</article-title>. <source>BMC Musculoskelet. Disord.</source> <volume>26</volume>:<fpage>666</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12891-025-08881-9</pub-id>, <pub-id pub-id-type="pmid">40629319</pub-id></mixed-citation></ref>
<ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rocha</surname><given-names>C. M.</given-names></name> <name><surname>Kawamoto</surname><given-names>D.</given-names></name> <name><surname>Martins</surname><given-names>F. H.</given-names></name> <name><surname>Bueno</surname><given-names>M. R.</given-names></name> <name><surname>Ishikawa</surname><given-names>K. H.</given-names></name> <name><surname>Ando-Suguimoto</surname><given-names>E. S.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Experimental inoculation of <italic>Aggregatibacter actinomycetemcomitans</italic> and <italic>Streptococcus gordonii</italic> and its impact on alveolar bone loss and oral and gut microbiomes</article-title>. <source>Int. J. Mol. Sci.</source> <volume>25</volume>:<fpage>8090</fpage>. doi: <pub-id pub-id-type="doi">10.3390/ijms25158090</pub-id>, <pub-id pub-id-type="pmid">39125663</pub-id></mixed-citation></ref>
<ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rougereau</surname><given-names>G.</given-names></name> <name><surname>Marty-Diloy</surname><given-names>T.</given-names></name> <name><surname>Vigan</surname><given-names>M.</given-names></name> <name><surname>Donadieu</surname><given-names>K.</given-names></name> <name><surname>Vialle</surname><given-names>R.</given-names></name> <name><surname>Langlais</surname><given-names>T.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>Biomechanical evaluation of the anterior talo-fibular and calcaneo-fibular ligaments using shear wave elastography in young healthy adults</article-title>. <source>Orthop. Traumatol. Surg. Res.</source> <volume>110</volume>:<fpage>103647</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.otsr.2023.103647</pub-id></mixed-citation></ref>
<ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname><given-names>M.</given-names></name> <name><surname>Limaye</surname><given-names>R.</given-names></name> <name><surname>Rai</surname><given-names>A.</given-names></name> <name><surname>Limaye</surname><given-names>N.</given-names></name></person-group> (<year>2023</year>). <article-title>Anterior talo-fibular ligament reconstruction with InternalBrace<sup>&#x2122;</sup> for chronic lateral ankle instability in Pediatric patients</article-title>. <source>Cureus</source> <volume>15</volume>:<fpage>e44979</fpage>. doi: <pub-id pub-id-type="doi">10.7759/cureus.44979</pub-id>, <pub-id pub-id-type="pmid">37822443</pub-id></mixed-citation></ref>
<ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>R.</given-names></name> <name><surname>Yu</surname><given-names>F.</given-names></name> <name><surname>Hu</surname><given-names>X.</given-names></name> <name><surname>Liu</surname><given-names>Y.</given-names></name> <name><surname>Jin</surname><given-names>Y.</given-names></name> <name><surname>Ren</surname><given-names>H.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Protective effect of <italic>Lactiplantibacillus plantarum</italic> subsp. <italic>plantarum</italic> SC-5 on dextran sulfate sodium-induced colitis in mice</article-title>. <source>Foods</source> <volume>12</volume>:<fpage>897</fpage>. doi: <pub-id pub-id-type="doi">10.3390/foods12040897</pub-id>, <pub-id pub-id-type="pmid">36832972</pub-id></mixed-citation></ref>
<ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sivalingam</surname><given-names>S.</given-names></name> <name><surname>Larsen</surname><given-names>E. L.</given-names></name> <name><surname>van Raalte</surname><given-names>D. H.</given-names></name> <name><surname>Muskiet</surname><given-names>M. H. A.</given-names></name> <name><surname>Smits</surname><given-names>M. M.</given-names></name> <name><surname>Tonneijck</surname><given-names>L.</given-names></name> <etal/></person-group>. (<year>2021</year>). <article-title>The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes</article-title>. <source>Sci. Rep.</source> <volume>11</volume>:<fpage>10624</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-90191-w</pub-id>, <pub-id pub-id-type="pmid">34012064</pub-id></mixed-citation></ref>
<ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Szmit</surname><given-names>M.</given-names></name> <name><surname>Krajewski</surname><given-names>R.</given-names></name> <name><surname>Rudnicki</surname><given-names>J.</given-names></name> <name><surname>Agrawal</surname><given-names>S.</given-names></name></person-group> (<year>2023</year>). <article-title>Application and efficacy of transcutaneous electrical acupoint stimulation (TEAS) in clinical practice: a systematic review</article-title>. <source>Adv. Clin. Exp. Med.</source> <volume>32</volume>, <fpage>1063</fpage>&#x2013;<lpage>1074</lpage>. doi: <pub-id pub-id-type="doi">10.17219/acem/159703</pub-id>, <pub-id pub-id-type="pmid">37026972</pub-id></mixed-citation></ref>
<ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Turpin</surname><given-names>W.</given-names></name> <name><surname>Bedrani</surname><given-names>L.</given-names></name> <name><surname>Espin-Garcia</surname><given-names>O.</given-names></name> <name><surname>Xu</surname><given-names>W.</given-names></name> <name><surname>Silverberg</surname><given-names>M. S.</given-names></name> <name><surname>Smith</surname><given-names>M. I.</given-names></name> <etal/></person-group>. (<year>2020</year>). <article-title>Associations of NOD2 polymorphisms with Erysipelotrichaceae in stool of in healthy first degree relatives of Crohn's disease subjects</article-title>. <source>BMC Med. Genet.</source> <volume>21</volume>:<fpage>204</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12881-020-01115-w</pub-id>, <pub-id pub-id-type="pmid">33059653</pub-id></mixed-citation></ref>
<ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vacca</surname><given-names>M.</given-names></name> <name><surname>Celano</surname><given-names>G.</given-names></name> <name><surname>Calabrese</surname><given-names>F. M.</given-names></name> <name><surname>Portincasa</surname><given-names>P.</given-names></name> <name><surname>Gobbetti</surname><given-names>M.</given-names></name> <name><surname>De angelis</surname><given-names>M.</given-names></name></person-group> (<year>2020</year>). <article-title>The controversial role of human gut Lachnospiraceae</article-title>. <source>Microorganisms</source> <volume>8</volume>:<fpage>573</fpage>. doi: <pub-id pub-id-type="doi">10.3390/microorganisms8040573</pub-id>, <pub-id pub-id-type="pmid">32326636</pub-id></mixed-citation></ref>
<ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vance</surname><given-names>C. G. T.</given-names></name> <name><surname>Dailey</surname><given-names>D. L.</given-names></name> <name><surname>Chimenti</surname><given-names>R. L.</given-names></name> <name><surname>Van Gorp</surname><given-names>B. J.</given-names></name> <name><surname>Crofford</surname><given-names>L. J.</given-names></name> <name><surname>Sluka</surname><given-names>K. A.</given-names></name></person-group> (<year>2022</year>). <article-title>Using TENS for pain control: update on the state of the evidence</article-title>. <source>Medicina</source> <volume>58</volume>:<fpage>1332</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medicina58101332</pub-id>, <pub-id pub-id-type="pmid">36295493</pub-id></mixed-citation></ref>
<ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y. H.</given-names></name> <name><surname>Yan</surname><given-names>Z. Z.</given-names></name> <name><surname>Luo</surname><given-names>S. D.</given-names></name> <name><surname>Hu</surname><given-names>J. J.</given-names></name> <name><surname>Wu</surname><given-names>M.</given-names></name> <name><surname>Zhao</surname><given-names>J.</given-names></name> <etal/></person-group>. (<year>2023</year>). <article-title>Gut microbiota-derived succinate aggravates acute lung injury after intestinal ischaemia/reperfusion in mice</article-title>. <source>Eur. Respir. J.</source> <volume>61</volume>:<fpage>2200840</fpage>. doi: <pub-id pub-id-type="doi">10.1183/13993003.00840-2022</pub-id>, <pub-id pub-id-type="pmid">36229053</pub-id></mixed-citation></ref>
<ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>D. H.</given-names></name> <name><surname>Nah</surname><given-names>H.</given-names></name> <name><surname>Lee</surname><given-names>D.</given-names></name> <name><surname>Min</surname><given-names>S. J.</given-names></name> <name><surname>Park</surname><given-names>S.</given-names></name> <name><surname>An</surname><given-names>S. H.</given-names></name> <etal/></person-group>. (<year>2024</year>). <article-title>A review on gold nanoparticles as an innovative therapeutic cue in bone tissue engineering: prospects and future clinical applications</article-title>. <source>Mater. Today Bio</source> <volume>26</volume>:<fpage>101016</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.mtbio.2024.101016</pub-id>, <pub-id pub-id-type="pmid">38516171</pub-id></mixed-citation></ref>
<ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zang</surname><given-names>Y.</given-names></name> <name><surname>Lai</surname><given-names>X.</given-names></name> <name><surname>Li</surname><given-names>C.</given-names></name> <name><surname>Ding</surname><given-names>D.</given-names></name> <name><surname>Wang</surname><given-names>Y.</given-names></name> <name><surname>Zhu</surname><given-names>Y.</given-names></name></person-group> (<year>2023</year>). <article-title>The role of gut microbiota in various neurological and psychiatric disorders-an evidence mapping based on quantified evidence</article-title>. <source>Mediat. Inflamm.</source> <volume>2023</volume>:<fpage>5127157</fpage>. doi: <pub-id pub-id-type="doi">10.1155/2023/5127157</pub-id>, <pub-id pub-id-type="pmid">36816743</pub-id></mixed-citation></ref>
<ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y.</given-names></name> <name><surname>Chen</surname><given-names>B.</given-names></name> <name><surname>Li</surname><given-names>S.</given-names></name> <name><surname>Yang</surname><given-names>L.</given-names></name> <name><surname>Zhu</surname><given-names>D.</given-names></name> <name><surname>Wang</surname><given-names>Y.</given-names></name> <etal/></person-group>. (<year>2018</year>). <article-title>Detection and characterization of bacterial nucleic acids in culture-negative synovial tissue and fluid samples from rheumatoid arthritis or osteoarthritis patients</article-title>. <source>Sci. Rep.</source> <volume>8</volume>:<fpage>14305</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-018-32675-w</pub-id>, <pub-id pub-id-type="pmid">30250232</pub-id></mixed-citation></ref>
<ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zong</surname><given-names>J.</given-names></name> <name><surname>Salim</surname><given-names>M.</given-names></name> <name><surname>Zhou</surname><given-names>H.</given-names></name> <name><surname>Bian</surname><given-names>Z. Y.</given-names></name> <name><surname>Dai</surname><given-names>J.</given-names></name> <name><surname>Yuan</surname><given-names>Y.</given-names></name> <etal/></person-group>. (<year>2013</year>). <article-title>NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload</article-title>. <source>Lab. Investig.</source> <volume>93</volume>, <fpage>1128</fpage>&#x2013;<lpage>1136</lpage>. doi: <pub-id pub-id-type="doi">10.1038/labinvest.2013.99</pub-id>, <pub-id pub-id-type="pmid">23958879</pub-id></mixed-citation></ref>
</ref-list>
<fn-group>
<fn fn-type="custom" custom-type="edited-by" id="fn0002">
<p>Edited by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/2394202/overview">S. L. Jia</ext-link>, Tianjin Medical University, China</p>
</fn>
<fn fn-type="custom" custom-type="reviewed-by" id="fn0003">
<p>Reviewed by: <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3164203/overview">Xi Wang</ext-link>, Institute of Microbiology, Chinese Academy of Sciences (CAS), China</p>
<p><ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/3346316/overview">Jing Yang</ext-link>, Ministry of Agriculture and Rural Affairs, China</p>
</fn>
</fn-group>
<fn-group>
<fn fn-type="abbr" id="abbrev1">
<label>Abbreviations:</label>
<p>ATFL, Anterior talo-fibular ligament; AB, Alcian blue; BMD, Bone mineral density; BMC, Bone mineral content; CAI, Chronic ankle instability; FMT, Fecal microbiota transplantation; IF, Immunofluorescence; Micro-CT, Micro-computed tomography; OTU, Operational taxonomic unit; PCR, Polymerase chain reaction; PBS, Phosphate buffered saline; SMI, Structure model index; TENS, Transcutaneous electrical nerve stimulation; TB.n, Trabecular bone number; TB.th, Trabecular bone thickness.</p>
</fn>
</fn-group>
</back>
</article>